Medications

FDA investigating PML in patient taking MS drug

(HealthDay)—The U.S. Food and Drug Administration is investigating the possible association between a rare brain infection and the multiple sclerosis (MS) drug Gilenya (fingolimod), according to a drug safety alert issued ...

Vaccination

FDA advisers weigh COVID-19 booster shots for fall

Outlining a daunting timeline for development of any updated COVID-19 vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin ...

Medications

Fearing abuse, US blocks generic OxyContin (Update)

U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.

Oncology & Cancer

NICE says 'not enough data' to approve drug for ovarian cancer

The National Institute for Health and Care Excellence (NICE) says it cannot give a positive decision over whether to recommend a new drug for ovarian cancer unless its makers provide more information on cost. A final decision ...

page 5 from 21